Xia Jin, MD/PhD, is currently a Professor and Principal Investigator and Executive Director of Vaccine Center at Institut Pasteur of Shanghai (IPS), Chinese Academy of Science. He had been a tenure-track Assistant (2001-2006) and Associate Professor (2007-2012) at University of Rochester, Rochester, New York, before joining IPS in 2012. He obtained a Medical Degree after completion of the 8-year Curriculum at Peking Union Medical College, and then a PhD degree in Viral Immunology from Open University under the tutelage of Professor Sir Patrick Sisson of Cambridge University Clinical School in England. His postdoctoral training was completed with Drs. Richard A. Koup and David D. Ho, respectively, at the Aaron Diamond AIDS Research Center in New York. While working in the US, he has been a Principal Investigator or Co-investigator of over 20 research grants from NIH and The Melinda & Gates Foundation. He has served as a member of numerous NIH study sections, and also as international expert reviewer for Netherland, Hongkong, Taiwan and Singapore research agencies. He has been the Chair (HVTN-064, HVTN-083) and Co-Chair (HVTN-063 and HVTN-094) of phase I clinical trial of HIV vaccines conducted by the HVTN of NIH/NIAID. He is an Academic Editor of PLoS ONE and Editorial Board Member of JAIDS. His laboratory works on HIV and dengue virus immunology and vaccine development. He has published over 80 SCI papers in Science, J Exp Med, J Clin Inv, J Immunol, J Virol, J Inf Dis, AIDS, Retrovirology, Vaccine etc, including a highly cited paper (Jin et al., J Exp. Med., 1999) in PubMed (462 time).